ArticleMolecular cancer therapeutics2022

Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity.

Dana Piovesan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.